Narrative review / 2008
Risk assessment identified Observed Safe Levels for supplemental taurine (3 g/d), L-glutamine (14 g/d), and L-arginine (20 g/d) in healthy adults.
Researchers performed a quantitative risk assessment to identify safe upper intake levels for oral taurine, L-glutamine, and L-arginine. Due to the absence of a systematic pattern of adverse effects in humans, a NOAEL, LOAEL, or UL could not be determined; instead, the Observed Safe Level (OSL) method was utilized. Strong evidence for the absence of adverse effects supported OSLs of up to 3 g/d for taurine, 14 g/d for L-glutamine, and 20 g/d for L-arginine in normal healthy adults. Although higher levels have been tested without adverse effects, data were considered insufficient for confident conclusions on long-term safety.
- Study type
- Safety review and quantitative risk assessment
- Who was studied
- Normal healthy adults based on published human clinical trial data
- What was measured
- Observed Safe Levels (OSL) and adverse effects of supplemental amino acids
THE PAPER
Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
Shao A, Hathcock JN. Regul Toxicol Pharmacol, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.